Table 5.

Examination data of patients treated with each antibiotic

	ESBL-nonproducing EC CTX	ESBL-nonproducing EC FMOX or CMZ	ESBL-producing EC CTX	ESBL-producing EC FMOX	ESBL-producing EC CMZ
n	21	33	16	53	9
Male	12	19	10	32	6
Age (month)	0–108 (median 3)	0–95 (median 4)	1–132 (median 4)	1–159 (median 5)	1–15 (median 3)
WBC	17,750 ± 6252	18,328 ± 6214	17,786 ± 6348	18,506 ± 6789	15,435 ± 6307
CRP	5.74 ± 4.91	5.98 ± 4.74	7.04 ± 4.24	9.84 ± 5.14	5.65 ± 3.78
Change the antibiotics case	0	0	4	1	1

ESBL-nonproducing EC-CTX upper urinary tract infection (UUTI) caused by extended-spectrum beta-lactamase not producing E. coli treated with cefotaxime sodium (CTX) or ceftriaxone disodium (CTRX); ESBL-nonproducing EC-FMOX or CMZ upper urinary tract infection (UUTI) caused by extended-spectrum beta-lactamase not producing E. coli treated with flomoxef (FMOX) or cefmetazole (CMZ); ESBL-producing EC-CTX UUTI caused by ESBL-producing E. coli treated with CTX or CTRX; ESBL-producing EC-FMOX UUTI caused by ESBL-producing E. coli treated with FMOX; and ESBL-producing EC-CMZ UUTI caused by ESBL-producing E. coli treated with CMZ are shown

WBC white blood cell, CRP C-reactive protein